Recent Company News

• 10:14 PM ET Mar 02, 2026
  

  StreetAccount Summary - Trading higher/lower: Japan mid-day

• 03:11 AM ET Apr 08, 2026
  

  Sumitomo Pharma to issue 51.3M shares by way of public offering; price TBD from 20-Apr to 23-Apr (¥2130.0000, 0)

• 02:37 AM ET Mar 30, 2026
  

  Sumitomo Pharma submits partial change application in Japan to add pediatric dosage and administration for LATUDA (¥2107.0000, 0)

• 10:27 AM ET Mar 12, 2026
  

  FDA grants orphan drug designation to DSP-3077 for retinitis pigmentosa (¥1866.0000, 0)

• 07:33 PM ET Mar 05, 2026
  

  Sumitomo Pharma obtains conditional and time-limited approval in Japan for producing and marketing of AMCHEPRY for treatment for Parkinson's disease (¥1864.0000, +19)

• 06:13 PM ET Mar 02, 2026
  

  Sumitomo Pharma files shelf registration statement for issuance of up to 60.0M new shares (¥2421.5000, 0)